HDAC11 Gene

HDAC11 Gene

Overview

HDAC11 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HDAC11 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HDAC11</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HDAC11</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=HDAC11" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/huntington" style="color:#ef9a9a">Huntington</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">58 edges</a></td>
</tr>
</table>

HDAC11 (Histone Deacetylase 11) is the sole member of the class IV histone deacetylase family, representing a unique branch of the HDAC superfamily distinguished by its distinctive structure, tissue-specific expression, and specialized biological functions. First identified in 2002, HDAC11 has emerged as a significant regulator of immune responses, metabolism, and neuronal function, making it a molecule of considerable interest for understanding and potentially treating neurodegenerative diseases.

The human HDAC11 gene is located on chromosome 3p25.2 and encodes a protein of 347 amino acids with a molecular weight of approximately 39 kDa, making it the smallest mammalian HDAC. Despite its small size, HDAC11 carries a functional catalytic domain and participates in diverse molecular interactions through multiple protein-protein interaction motifs.

In the nervous system, HDAC11 is highly expressed in various brain regions including the cerebral cortex, hippocampus, cerebellum, and basal ganglia, with particular enrichment in neurons and, to a lesser extent, glial cells. The enzyme regulates gene expression through both histone deacetylation (canonical HDAC activity) and non-histone protein modifications, contributing to the control of immune responses, metabolic processes, and neuronal survival pathways.

Unlike other HDAC classes (I, II, and III), HDAC11 remains relatively poorly characterized, though recent research has begun to illuminate its specific biological roles and therapeutic potential. Its restricted expression pattern and unique structural features suggest specialized functions that may be exploited for therapeutic benefit in conditions ranging from cancer to autoimmune disorders to neurodegenerative diseases.

Gene Structure and Evolution

Genomic Organization

The HDAC11 gene spans approximately 17 kb on chromosome 3p25.2 and consists of 13 exons encoding a single protein isoform. The gene structure is compact relative to other HDAC family members, reflecting the smaller size of the encoded protein.

Key gene features:

• Promoter region: Contains multiple transcription factor binding sites including Sp1, NF-κB, and STAT motifs
• Exon structure: 13 exons of variable length, with exons 1-4 encoding the catalytic domain
• Alternative splicing: Limited evidence for alternative splicing; the major isoform is the full-length protein

Evolutionary Conservation

HDAC11 is conserved across vertebrates but shows limited orthology to invertebrate proteins:

• Mammalian HDAC11 orthologs share >90% amino acid identity
• Zebrafish and avian orthologs retain key functional domains
• Drosophila melanogaster lacks a clear HDAC11 ortholog, suggesting relatively recent evolutionary origin

Protein Structure

HDAC11 adopts a compact structure unique among HDACs:

Catalytic domain:

• Located in the N-terminal region (residues 1-200)
• Contains the characteristic HDAC active site motif HxDxxH
• Requires zinc ion (Zn²⁺) for catalytic activity
• Shows substrate preference for acetylated lysine residues

• Short N-terminal extension not found in other HDACs
• Extended loop regions contributing to substrate specificity
• Lacks the additional domains present in class II HDACs (e.g., LRR, zinc fingers)

• Phosphorylation sites (Ser-274, Thr-317) may regulate activity and localization
• Acetylation sites may affect protein-protein interactions
• SUMOylation potential at Lys-89

Expression and Cellular Distribution

Tissue Expression

HDAC11 demonstrates tissue-selective expression:

High expression:

• Brain (neurons, particularly in cortex and hippocampus)
• Kidney (renal tubular cells)
• Heart (cardiac myocytes)
• Skeletal muscle (type I fibers)
• Testis (spermatogenic cells)

• Liver (hepatocytes)
• Lung (alveolar epithelium)
• Spleen (immune cells)
• Adrenal gland

• Most other tissues show minimal HDAC11 expression

Brain Expression

Within the central nervous system, HDAC11 is expressed in:

Neuronal populations:

• Cerebral cortex (layer 5 pyramidal neurons especially)
• Hippocampus (CA1-CA3 pyramidal cells, dentate granule cells)
• Cerebellum (Purkinje cells)
• Basal ganglia (striatal medium spiny neurons)
• Brainstem (various nuclei)

• Astrocytes (moderate expression)
• Microglia (lower expression than astrocytes)
• Oligodendrocytes (limited expression)

Subcellular Localization

HDAC11 localizes primarily to the nucleus in most cell types:

• Nuclear localization signal (NLS) at residues 80-85
• May shuttle between nucleus and cytoplasm under certain conditions
• Association with nuclear speckles and transcriptional complexes

Biological Functions

Immune Regulation

HDAC11 plays a crucial role in modulating immune responses:

T-cell biology:

• Regulates T-cell activation and differentiation
• Promotes Th2 polarization through IL-4 gene regulation
• Modulates regulatory T-cell (Treg) function
• Controls cytokine production in effector T-cells

• Regulates macrophage activation states
• Modulates dendritic cell maturation
• Controls neutrophil responses

• Deacetylates STAT3, affecting cytokine signaling
• Modulates NF-κB activity through IκBα stabilization
• Regulates Foxp3 expression in Tregs

Metabolism

HDAC11 influences metabolic processes:

Lipid metabolism:

• Regulates fatty acid oxidation genes
• Modulates cholesterol biosynthesis
• Affects lipid droplet formation

• Influences gluconeogenesis gene expression
• Modulates insulin signaling components

• HDAC11 metabolic effects have implications for metabolic diseases
• May affect neuronal energy metabolism in neurodegeneration

Neuronal Function

In neurons, HDAC11 contributes to:

Gene regulation:

• Controls neuronal gene expression programs
• Modulates immediate-early gene activation
• Regulates synaptic plasticity-related genes

• Responds to oxidative stress
• Modulates DNA damage responses
• Influences apoptotic pathways

• Regulates synapse-associated gene expression
• May affect long-term potentiation (LTP)

Role in Neurodegenerative Diseases

Alzheimer's Disease

HDAC11 alterations in AD:

Expression changes:

• HDAC11 expression is elevated in AD prefrontal cortex and hippocampus
• This elevation correlates with disease progression
• Astrocytic HDAC11 shows particularly strong upregulation

• Enhanced neuroinflammation through increased cytokine/chemokine expression
• Impaired neuronal gene regulation affecting synaptic function
• Potential effects on amyloid processing genes

• HDAC11 inhibition may reduce neuroinflammation
• Selective HDAC11 inhibitors in development
• May need to balance anti-inflammatory effects with potential synaptic impacts

Parkinson's Disease

HDAC11 in PD models:

Molecular alterations:

• Altered HDAC11 expression in substantia nigra
• Effects on dopaminergic neuron survival pathways
• Modulation of neuroinflammation in PD models

• Regulation of α-synuclein expression
• Effects on mitochondrial function genes
• Neuroinflammation modulation

Neuroinflammation

HDAC11 as a key regulator:

Microglial activation:

• HDAC11 promotes pro-inflammatory gene expression in microglia
• HDAC11 deletion reduces microglial activation markers
• Affects NLRP3 inflammasome and cytokine production

• HDAC11 inhibition reduces neuroinflammation in mouse models
• Potential for treating chronic neuroinflammatory conditions
• Must consider immune surveillance functions

Therapeutic Implications

HDAC11 as Drug Target

HDAC11 represents a promising therapeutic target:

Advantages:

• Tissue-restricted expression may reduce side effects
• Unique structure allows selective targeting
• Distinct from other HDAC isoforms

• First-generation HDAC11 inhibitors entering preclinical development
• Phenotypic screening has identified HDAC11-selective compounds
• Structure-based design enabling selectivity

Disease Applications

Neurodegenerative diseases:

• Chronic neuroinflammation in AD, PD, MS
• May enhance cognitive function through gene regulation

• T-cell-mediated diseases
• Inflammatory conditions

• Tumor immunology applications
• Immune checkpoint modulation

Interaction Partners

HDAC11 interacts with various proteins:

Transcriptional regulators:

• STAT3: HDAC11 deacetylates and modulates STAT3 signaling
• NF-κB (p65): Influences NF-κB-dependent transcription
• Foxp3: Regulates Treg function

• HDAC1/2: May form complexes
• HDAC6: Potential functional interactions

• Various kinases and phosphatases
• Metabolic enzymes

Research Methods

Detection and Analysis

Molecular biology tools:

• qPCR for HDAC11 mRNA
• Western blot with specific antibodies
• Immunohistochemistry for tissue localization
• ChIP-seq for genomic targets

Functional Studies

Genetic approaches:

• CRISPR-Cas9 knockout in cell lines
• siRNA/shRNA knockdown
• Transgenic mouse models

• First-generation HDAC11 inhibitors
• HDAC pan-inhibitors with HDAC11 activity
• HDAC activators may affect HDAC11

Future Directions

Research priorities for HDAC11 include:

External Resources

• [NCBI Gene: HDAC11](https://www.ncbi.nlm.nih.gov/gene/79868)
• [UniProt: HDAC11](https://www.uniprot.org/uniprot/Q9UKV0)
• [Allen Brain Atlas: HDAC11 expression](https://brain-map.org/)
• [PubMed: HDAC11 neuroscience](https://pubmed.ncbi.nlm.nih.gov/?term=HDAC11+neurodegeneration)

Summary

HDAC11 is the sole member of the class IV histone deacetylase family, with unique structural features and specialized biological functions. In the nervous system, HDAC11 regulates immune responses, gene expression, and neuronal function. Elevated HDAC11 expression in Alzheimer's disease and other neurodegenerative conditions suggests potential involvement in disease pathogenesis, particularly through modulation of neuroinflammation. While HDAC11 remains less well-characterized than other HDAC family members, emerging research indicates it represents a promising therapeutic target for conditions involving chronic neuroinflammation and immune dysregulation. Development of selective HDAC11 inhibitors with brain penetration is an active area of research with potential for future clinical application in neurodegenerative diseases.

References

See Also

• [ad-sphingolipid-ceramide-companies](/wiki/companies-ad-sphingolipid-ceramide-companies) — regulates
• [Alzheimer Hippocampal Circuit](/wiki/circuits-alzheimer-hippocampal-circuit) — regulates
• [Brain-Derived Neurotrophic Factor (BDNF)](/wiki/proteins-bdnf) — regulates
• [HDAC1 Gene](/wiki/genes-hdac1) — expressed_in
• [HDAC2 Gene](/wiki/genes-hdac2) — expressed_in
• [HDAC3 Gene](/wiki/genes-hdac3) — expressed_in
• [HDAC3 Gene](/wiki/genes-hdac3) — interacts_with
• [HDAC5 (Histone Deacetylase 5) Protein](/wiki/proteins-hdac5) — interacts_with

Pathway Diagram

The following diagram shows the key molecular relationships involving HDAC11 Gene discovered through SciDEX knowledge graph analysis: